Saphena Medical has raised $3m in its series A round from a consortium including medical-equipment maker STD Med.
Pavilion Medical Innovations, which incubates and commercializes medical technologies, also invested in Saphena Medical, a device company developing technology to harvest veins for use in coronay artery bypass grafting.
Michael Glennon, founder of Pavilion and who will serve as president of Saphena Medical, said: “This funding and our close working relationship with the experts at STD Med will enable Saphena Medical to…
